Navigation Links
Paradigm Spine Welcomes Hallett Mathews, MD, MBA As Its Executive Vice President & Chief Medical Officer
Date:9/12/2012

NEW YORK, Sept. 12, 2012 /PRNewswire/ -- Paradigm Spine, LLC, a leading provider of non-fusion "surgeon-centric" spinal implant and medical device technologies, announces the hire of one of the spine industry's leading visionaries, practitioners, and clinical authorities, Hallett Mathews, MD, MBA.

Dr. Mathews has joined the Company as its Executive Vice President and Chief Medical Officer, with global responsibility for all medical education initiatives, surgeon/faculty training functionalities, and is tasked with the strategic management of the Company's clinical, compliance and regulatory policies, as they relate to its worldwide product portfolio of spine medical devices.

Dr. Mathews is a board certified orthopedic spinal surgeon who practiced spinal surgery for 22 years. He is considered a pioneering and innovative spine surgeon, national surgeon educator, society leader, researcher, and patient advocate, and is recognized by his peers as a pioneer of minimally invasive spine surgery. Dr. Mathews was recruited from clinical practice by Medtronic Spine and Biologics in 2005 to become their Vice President of Medical Affairs, and later served within the capacity of Vice President of Clinical Affairs, ultimately becoming Chief Medical Officer. Prior to joining Medtronic, he was President of MidAtlantic Spine Specialists in Richmond and Williamsburg, VA, where he owned and practiced in a private multi-disciplinary spine surgery practice. Also, prior to joining Medtronic, Dr. Mathews was an Associate Clinical Professor of Orthopedic and Neurologic Surgery at Virginia Commonwealth University in Richmond, VA.

Dr. Mathews stated "Paradigm Spine as an organization represents true comparative effectiveness research and innovation that strives to help patients, physicians and key stakeholders understand the need to improve quality and patient outcomes in spine care. Over the last 20 years, there have been few, if any, prospective, randomized control
'/>"/>

SOURCE Paradigm Spine, LLC
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Human Vaccines & Immunotherapeutics Special Focus Highlights a Paradigm Shift in Cancer Vaccine Development
2. Comprehensive Spine Symposium: Sept. 21
3. International Spine Products Manufacturer Featured in Upcoming US Business Executive Publication - www.gsmedicalusa.com
4. Interventional Spine Announces its 75th Patient Treated with the PerX360 Percutaneous Spinal Fusion Technology
5. SpineMark Corporation Partners with PhDx and Millennium Environmental to Create an ISO type Spine Protocol Management System
6. Misonix Adds 6 Spine Sales Agencies In The U.S.
7. Global Information Inc Offers Big Discounts on Market Forecasts for Surgical Sealants, Wound Closure Products, Spine Surgery Technology, and More
8. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
9. Misonix Attends International Meeting On Advanced Spine Techniques (IMAST) - Introduces New Product
10. Misonix Participates In Cleveland Spine Review
11. Misonix Exhibits at Major Worldwide Spine Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... 2013  Lehigh Valley Health Network has announced the ... adding to its existing arsenal of five 5-foot-5 germ-killing ... within the network, LVHN is now deploying the largest ... superbugs and provide the best possible patient care available. ... TRU-D – the signature product of Memphis ...
(Date:5/21/2013)...  Janssen R&D Ireland (Janssen) today announced primary ... 3 PROMISE study demonstrating that use of the ... virologic response 12 weeks after the end of ... 1 chronic hepatitis C adult patients with compensated ... when administered once daily with pegylated interferon and ...
(Date:5/21/2013)... , May 21, 2013  BioRestorative Therapies, Inc. ... sciences company focused on developing stem cell based therapies ... Weinreb , its President and CEO, will be ... The conference will be held on Thursday, May 30, ... E 42nd Street in New York City.  Mr. Weinreb,s ...
Breaking Medicine Technology:Lehigh Valley Expands Fleet of Superbug-Slaying Robots 2Lehigh Valley Expands Fleet of Superbug-Slaying Robots 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
... , , , ... academic, private and government cancer drug discovery efforts , ... Research Institute today announced that it has been selected as ... Institute,s (NCI) Chemical Biology Consortium (CBC)--a program meant to coordinate ...
... , , , ... N.J., Aug. 19 Newly published data in The New ... (letrozole tablets) following surgery as an optimal treatment approach versus tamoxifen ... , The data include an analysis from the ...
Cached Medicine Technology:Southern Research to Play Key Role in the Federal Government's Search for New Cancer Therapies 2Southern Research to Play Key Role in the Federal Government's Search for New Cancer Therapies 3Southern Research to Play Key Role in the Federal Government's Search for New Cancer Therapies 4Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 2Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 3Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 4Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 5Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 6Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 7Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 8Results In 'The New England Journal Of Medicine' Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery 9
(Date:5/21/2013)... Nearly 40 Platinum Supplemental Insurance Sales Representatives ... Los Cabos, Mexico, Feb. 23-March 1, 2013, to help renovate ... The facility serves meals and provides a social outlet for ... , Platinum Vice President, Mike Muench, says that the idea ... , “Platinum got its start selling long-term care insurance ...
(Date:5/21/2013)... May 21, 2013 Dimensional Insight, a ... announced that Western Maryland Health System, a ... The Diver Solution™ (Diver) to help it analyze its ... first customer to purchase Diver through Dimensional Insight’s recently ... Like most hospitals, Western Maryland has massive amounts of ...
(Date:5/21/2013)... Tools4ever, the market leader in Identity & Access ... Password Management (SSRPM) suitable for BYOD. With the latest ... on mobile systems i.e.; laptops, tablets, handheld computers and ... Windows passwords anywhere, anytime. Once the end user has ... then reset his or her own password. , ...
(Date:5/21/2013)... TUESDAY, May 21 (HealthDay News) -- Thousands of ... from the lung condition known as chronic obstructive ... that patients placed on the common antibiotic azithromycin ... due to flare-ups of the disease. "Given ... of such events is critical," said Victoria Richards, ...
(Date:5/21/2013)... ─ Clinical measurement of physical activity appears to ... patients with chronic obstructive pulmonary disease (COPD) will ... study conducted by researchers in Connecticut. The study ... levels of inactivity with an increased incidence of ... of the study will be presented at the ...
Breaking Medicine News(10 mins):Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 2Health News:Platinum Supplemental Insurance Gives Back at Casa De Dia, Mexico 3Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 2Health News:Dimensional Insight Announces Western Maryland Health System as First Customer Through Premier Healthcare Alliance 3Health News:Tools4ever’s password reset software ready for BYOD 2Health News:Long-Term Use of Antibiotic May Help Those With COPD 2Health News:Long-Term Use of Antibiotic May Help Those With COPD 3Health News:Exercise levels may predict hospitalizations in COPD population 2
... Dec. 13, Speaker Nancy Pelosi,issued the following statement ... Leader George Mitchell, which found widespread use,of steroids and ... Mitchell Report tells a troubling story of how many ... the fans of our national,pastime by using steroids and ...
... Poll Shows Rural Seniors Want E-Prescribing in Medicare, ... so many issues, promoting electronic prescribing (e-prescribing) in,Medicare ... and Democrats can,agree on. "The Medicare Electronic Medication ... require that Medicare physicians begin to,prescribe electronically, will ...
... The University of Illinois at Chicago College of Nursing has ... people as they transition to the end of life. ... the science of care for people of all ages facing ... funded through a $2.4 million grant from the National Institute ...
... side effects, including heart trouble , , THURSDAY, Dec. 13 ... Andy Pettitte, Houston Astros All-Star shortstop Miguel Tejada and ... players cited in a highly anticipated report into the ... , The report climaxed a 20-month probe by former ...
... 13 The Quantum Group,Inc. (Amex: QGP, QGP.U) ... its registered public offering, raising $13.2 million in,gross ... initiated trading,on the American Stock Exchange (AMEX) of ... "QGP.U." In addition, Quantum common shares,formerly traded on ...
... Dec. 13 Repligen Corporation,(Nasdaq: RGEN ) ... has been,elected to its Board of Directors. Dr. ... and regulatory expertise in the,development of therapeutics for ... very pleased to welcome an executive with Earl,s ...
Cached Medicine News:Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 2Health News:One Thing Washington Can Agree On: Time for E-Prescribing in Medicare 3Health News:New UIC center to study end-of-life transition 2Health News:New UIC center to study end-of-life transition 3Health News:Report Finds 'Widespread Steroid Use in Baseball' 2Health News:Report Finds 'Widespread Steroid Use in Baseball' 3Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 2Health News:The Quantum Group, Inc. Completes $13.2 Million Public Offering and Initiates Trading on the American Stock Exchange Under Symbol 'QGP' 3Health News:Repligen Elects Earl Henry, M.D. to the Board of Directors 2Health News:Repligen Elects Earl Henry, M.D. to the Board of Directors 3
Storage temperature: 15 - 30C, linearity: 0 - 20 mg/dL, expected value: male: 3.0 - 7.0 mg/dL and female: 2.2 - 6.2 mg/dL. Available with calibrator and number of tests 125....
For the quantitative determination of Uric Acid in serum. Linearity: 25 mg/dl....
... for small and medium volume laboratories, as ... System offers the speed, simplicity and flexibility ... Compact yet powerful, the Elecsys 1010 system ... response assays to routine testing without sacrificing ...
Sample throughput of up to 80 tests per hour (4 modules). Low maintenance requirements. Continuous random access. 25 - 100 channels on board. 1008 tests or 6 hours of walkaway operation....
Medicine Products: